Insight Molecular Diagnostics (IMDX) Net Income (2015 - 2026)

Insight Molecular Diagnostics has disclosed Net Income across 12 years of filings, most recently posting -$4.4 million for Q1 2026.

• Net Income for Q1 2026 came in at -$4.4 million, up 35.09% year-over-year; the trailing twelve-month figure through Mar 2026 was -$8.2 million (up 20.54% YoY), and the FY2025 annual result was -$10.5 million, up 17.21% from the prior year.
• Net Income came in at -$4.4 million for Q1 2026 at Insight Molecular Diagnostics, down from $17.1 million in the prior quarter.
• In the past five years, Net Income ranged from a high of $17.1 million in Q4 2025 to a low of -$33.0 million in Q4 2022.
• The 5-year median for Net Income is -$6.9 million (2022), against an average of -$6.1 million.
• Across the five-year window, Net Income jumped 57.46% in 2023 and sank 212.0% in 2024, its largest moves.
• Insight Molecular Diagnostics' Net Income stood at -$33.0 million in 2022, then surged by 91.12% to -$2.9 million in 2023, then surged by 601.54% to $14.7 million in 2024, then advanced by 16.81% to $17.1 million in 2025, then tumbled by 125.74% to -$4.4 million in 2026.
• The last three Net Income figures came in at -$4.4 million (Q1 2026), $17.1 million (Q4 2025), and -$11.0 million (Q3 2025), per Business Quant data.